Contra

Date 29 September 2014
Event ESMO 2014
Session Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT)
Topics Anti-Cancer Agents & Biologic Therapy
Prostate Cancer
Presenter Ian Tannock
Authors I.F. Tannock
  • Dept Of Medical Oncology, Princess Margaret Hospital, M5G 2M9 - Toronto/CA